Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001708649-21-000001
Filing Date
2021-01-05
Accepted
2021-01-05 09:13:37
Documents
1
Effectiveness Date
2021-01-05
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9653
  Complete submission text file 0001708649-21-000001.txt   10821
Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 484-899-0326
CARISMA Therapeutics Inc. (Filer) CIK: 0001708649 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-385203 | Film No.: 21504093